Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease: An 8-year follow-up in the Copenhagen male study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1114-1120

  Jeppesen, Jørgen ^a   Hein, Hans Ole ^a,b   Suadicani, Poul ^a   Gyntelberg, Finn ^a  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dyslipidemia; High density lipoprotein choleslerol; Ischemic heart disease; Low density lipoprotein cholesterol; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; DENMARK; DYSLIPIDEMIA; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030974651     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1114     Document Type: Article

References (37)

1. Reaven GM. Syndrome X: 6 years later. J Intern Med. I994;236: 13-22.
2. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
3. Havel RJ, Rapaport E. Drug therapy: management of primary hyperlipidemia. N Engl J Med. 1995;332:1491-1498.
4. Wayne HHS, Shieh SM, Fuh MMT. Shen DDC, Jeng CY, Chen YDD, Reaven GM. Insulin resistance, glucose intolerance, and hyperinsulinemia: hypertriglyceridemia versus hypercholesterolemia. Arterioscler Thromb. 1993;13:367-370.
5. Gyntelberg F. Physical fitness and coronary heart disease in male residents in Copenhagen aged 40-59. Dan Med Bull. 1973;20:1-4.
6. Gyntelberg F. One- and two-years incidence of myocardial infarction in Copenhagen males aged 40-59. Dan Med Bull. 1975;22:81-84.
7. Suadicani P, Hein HO, Gyntelberg F. Serum cotinine validated form of smoking does not account for social inequalities in risk of ischaemic heart disease: the Copenhagen Male Study: 4 years' follow-up. Int J Epidemiol. 1994;23:293-300.
8. Svalastoga K. Prestige, Class and Motility. Copenhagen, Denmark: Munksgaard; 1959.
9. Rose GA, Holland WW, Crowley EA. A sphygmomanometer for epidemiologists. Lancet. 1964; 1:296-300.
10. Siedel J, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for the determination of serum cholesterol. J Clin Chem Biochem. 1981;19:838-839.
11. Stahler F, Gruber W, Stinshoff K, Roschlau P. Eine praxis gerechte enzymatische Cholesterin-Bestimmung. Med Lab (Stuttg). 1977;30: 29-37.
12. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. Lipid Res. 1970; 11:583-595.
13. Lopes-Virella MF. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 1977; 23:882-884.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499-502.
15. Norusis M. SPSS/PC+ Base Manual. Chicago, 111: SPSS Inc; 1988.
16. Norusis M. SPSS/PC+ Advanced Statistics. Chicago, 111: SPSS Inc; 1988.
17. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med. 1988;148:36-69.
18. Kinosian B, Click H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 1994; 121:641-647.
19. Abbott WGH, Lillioja S, Young AA, Zawadzki JK, Yki-Järvinen H, Christin L, Howard BV. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. Diabetes. 1987:36;897-904.
20. Garg A, Helderman JH, Koffler M, Ayoso R, Rosenstock J, Raskin P. Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism. 1988;37:982-987.
21. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis. 1990;10:223-232.
22. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med. 1992;231:25-30.
23. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest. 1993;92:141-146.
24. Tobey TA, Greenfield M, Kraemer F, Reaven GM. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. Metabolism. 1981;30:165-171.
25. Miesenböck G, Patsch JR. Relationship of triglyceride and high density lipoprotein metabolism. Atheroscler Rev. 1990;21:119-127.
26. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11:2-14.
27. Hulley SB, Rosenman RH, Bawal RD, Brand RJ. Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart diseases. N Engl J Med. 1980;302:1383-1389.
28. Criqui MH, Heiss G, Cohn R, Cowan LD, Suchindran CM, Bangdiwila S, Kritchevsky S, Jacobs DR, O'Grady HK, Davis CE. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993:328:1220-1225.
29. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willen WS, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1922.
30. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 1994;106:83-97.
31. Hamsten A, Wiman B, Defaire U, Blombäck M. Increased plasma level of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. I985;313: 1557-1563.
32. Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol. 1987; 9:263-268.
33. Moor E, Silveira A, Van't Hooft F, Suontaka AM, Eriksson P, Blombäck M, Hamsten A. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Arterioscler Thromb Vase Biol. 1995:15:655-664.
34. Bainton D, Miller NE, Bolton CH, Yarnell JWG, Sweetnam PM, Baker IA, Lewis B, Elwood PC. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men: the Caerphilly and Speedwell Collaborative Heart Disease Studies. Br Heart J. 1992;68:60-66.
35. Castelli WP. Epidemiology of triglycerides: a view from Framingham. Am J Cardiol. 1992;70:3H-9H.
36. Båvenholm P, Proudler A, Tornwall P, Godsland I, Landou C, De Faire U, Hamsten A. Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation. 1995;92:1422-1429.
37. Assmann G, Schulte H. Triglycerides and atherosclerosis: results from the Prospective Cardiovascular Münster Study. Atheroscler. Rev. 1991;22:51-57.